XHB

XHB remains in a Stage 2 advancing regime with a medium-term bullish bias supported by the rising 50DMA, despite the active Bullish Exhaustion pattern indicating waning upside momentum. Price is consolidating below the flat/declining 9EMA and 21EMA but continues to hold above the 50DMA. Under the Stable strategy, patient engagement is warranted—waiting for either a clear reclaim of the shorter EMAs or confirmation of support at the 50DMA before committing.

• ↑Mortgage rates hit seven-week low, likely boosting homebuyer activity this summer
• ↑AUM rose 37.7% to $2.07 B last month, reflecting strong ETF inflows
• ↓FY1 sales growth is negative, raising concerns about future revenue momentum